UK markets closed

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (I54.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
1.0200-0.0400 (-3.77%)
At close: 03:29PM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
716,912
716,912
533,881
354,555
253,542
Cost of revenue
210,878
210,878
142,131
107,115
86,549
Gross profit
506,034
506,034
391,750
247,440
166,993
Operating expenses
Research development
474,371
474,371
699,167
558,485
276,306
Selling general and administrative
349,086
349,086
313,660
230,152
62,053
Total operating expenses
812,102
812,102
997,751
776,005
547,252
Operating income or loss
-306,068
-306,068
-606,001
-528,565
-380,259
Interest expense
99,844
99,844
56,139
39,425
22,537
Income before tax
-380,156
-380,156
-601,353
-545,643
-476,691
Income tax expense
2,796
2,796
804
0
0
Income from continuing operations
-382,952
-382,952
-602,157
-545,643
-476,691
Net income
-382,951
-382,951
-601,945
-545,576
-428,091
Net income available to common shareholders
-382,951
-382,951
-601,945
-545,576
-428,091
Basic EPS
-1.30
-0.96
-1.58
-1.38
-1.08
Diluted EPS
-1.30
-0.96
-1.58
-1.38
-1.08
Basic average shares
399,398
398,314
381,004
396,688
396,688
Diluted average shares
399,398
398,314
381,004
396,688
396,688